Stock data
Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. (GLSI) reported net income of -US$19.36M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$19.45M | -US$19.36M | — |
| 2024 | — | — | -US$17.64M | -US$17.41M | — |
| 2023 | — | — | -US$9.33M | -US$8.89M | — |
| 2022 | — | — | -US$8.04M | -US$7.83M | — |
| 2021 | — | — | -US$4.60M | -US$4.57M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.95M | — |
| 2026-03-31 | — | -US$5.66M | — |
| 2025-12-31 | — | -US$8.71M | — |
| 2025-09-30 | — | -US$4.15M | — |
| 2025-06-30 | — | -US$3.75M | — |
| 2025-03-31 | — | -US$2.74M | — |
| 2024-12-31 | — | -US$9.67M | — |
| 2024-09-30 | — | -US$2.67M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.